Sanotize Research & Development Corp.
$5,375.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- February 1, 2022 – March 31, 2022
- Reference
- nrc-cnrc:172-2021-2022-Q4-985935
Published purpose
Conduct in vitro studies for effectiveness of a Nitric Oxide nasal spray on SARS-CoV-2 variants.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions